Skip to Main Content

Paper Details

Type 2 inflammation reduces SARS-CoV-2 replication in the airway epithelium in allergic asthma through functional alteration of ciliated epithelial cells.
J Allergy Clin Immunol
9
2023
Author NameAffiliation
Matthew C AltmanBenaroya Research Institute at Virginia Mason, University of Washington School of Medicine
Matthew J DufortBenaroya Research Institute at Virginia Mason
Lucille M RichCenter for Immunity and Immunotherapies, Seattle Children's Research Institute
Alkis TogiasNational Institute of Allergy and Infectious Diseases/National Institutes of Health
Daniel J JacksonUniversity of Wisconsin School of Medicine and Public Health
Jason S DebleyCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle Children's Hospital, University of Washington
  • 1 - 6

Datasets